Prostate Cancer Trial, Recruiting NCT04552509 Sponsor: Linda Chan, MD Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT04552509
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer) confirmed by a tissue sample (biopsy), with the biopsy taken within 12 months of joining the trial in most cases (confirm with trial site for exceptions)
  • People whose cancer is classified as Stage I through Stage IV with no confirmed spread to distant parts of the body, based on physical examination, CT scan, MRI, or bone scan
  • People whose prostate is no larger than 100 cc in volume, as measured by CT or ultrasound taken within 90 days before joining (this is recommended but not strictly required — confirm with trial site)
  • People who are in good to very good general health, able to carry out daily activities with no or minimal limitations (rated 0 or 1 on a standard health scale used by doctors)
  • People who have completed the required patient questionnaires for the trial
  • People who have signed a consent form agreeing to take part

Who may not be able to join:

  • People who have previously had surgery to remove the prostate (prostatectomy) or had cryotherapy (a freezing treatment) applied to the prostate
  • People who have previously received radiation therapy to the prostate or the lower pelvic area
  • People who have implanted hardware or other materials in their body that, in the opinion of the treating doctor, would interfere with treatment planning or delivery (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Linda Chan, MD, Memorial Health Services

Phone: 562-933-0300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Linda Chan, MD
Registry
ClinicalTrials.gov
Start date
5 June 2018
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Local control

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov